HEADER TRANSFERASE 01-FEB-03 1NUP TITLE CRYSTAL STRUCTURE OF HUMAN CYTOSOLIC NMN/NAMN ADENYLYLTRANSFERASE TITLE 2 COMPLEX WITH NMN COMPND MOL_ID: 1; COMPND 2 MOLECULE: FKSG76; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: NMN/NAMN ADENYLYLTRANSFERASE; COMPND 5 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: FKSG76; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: DH10-BETA; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PPROEX KEYWDS NAD BIOSYNTHESIS, MITOCHONDRIA, PYRIDINE ADENYLYLTRANSFERASE, ENZYME KEYWDS 2 CATALYSIS, TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR X.ZHANG,O.V.KURNASOV,S.KARTHIKEYAN,N.V.GRISHIN,A.L.OSTERMAN,H.ZHANG REVDAT 5 16-AUG-23 1NUP 1 REMARK REVDAT 4 16-NOV-11 1NUP 1 HETATM REVDAT 3 13-JUL-11 1NUP 1 VERSN REVDAT 2 24-FEB-09 1NUP 1 VERSN REVDAT 1 03-JUN-03 1NUP 0 JRNL AUTH X.ZHANG,O.V.KURNASOV,S.KARTHIKEYAN,N.V.GRISHIN,A.L.OSTERMAN, JRNL AUTH 2 H.ZHANG JRNL TITL STRUCTURAL CHARACTERIZATION OF A HUMAN CYTOSOLIC NMN/NAMN JRNL TITL 2 ADENYLYLTRANSFERASE AND IMPLICATION IN HUMAN NAD JRNL TITL 3 BIOSYNTHESIS JRNL REF J.BIOL.CHEM. V. 278 13503 2003 JRNL REFN ISSN 0021-9258 JRNL PMID 12574164 JRNL DOI 10.1074/JBC.M300073200 REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH T.ZHOU,O.KURNASOV,D.R.TOMCHICK,D.D.BINNS,N.V.GRISHIN, REMARK 1 AUTH 2 V.E.MARQUEZ,A.L.OSTERMAN,H.ZHANG REMARK 1 TITL STRUCTURE OF HUMAN NICOTINAMIDE/NICOTONIC ACID REMARK 1 TITL 2 MONONUCLEOTIDE ADENYLYLTRANSFERASE BASIS FOR THE DUAL REMARK 1 TITL 3 SUBSTRATE SPECIFICITY AND ACTIVATION OF THE ONCOLYTIC AGENT REMARK 1 TITL 4 TIAZOFURIN REMARK 1 REF J.BIOL.CHEM. V. 277 13148 2002 REMARK 1 REFN ISSN 0021-9258 REMARK 1 DOI 10.1074/JBC.M111469200 REMARK 2 REMARK 2 RESOLUTION. 1.90 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS 1.1 REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : ENGH & HUBER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.90 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 28.74 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 98.9 REMARK 3 NUMBER OF REFLECTIONS : 37359 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.200 REMARK 3 FREE R VALUE : 0.242 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 1879 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.006 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 6 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.90 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.02 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 97.40 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 5698 REMARK 3 BIN R VALUE (WORKING SET) : 0.2250 REMARK 3 BIN FREE R VALUE : 0.2760 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 5.00 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 300 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.016 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3405 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 64 REMARK 3 SOLVENT ATOMS : 276 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 21.20 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 29.80 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -1.46000 REMARK 3 B22 (A**2) : -1.46000 REMARK 3 B33 (A**2) : 2.92000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.21 REMARK 3 ESD FROM SIGMAA (A) : 0.07 REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.27 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.13 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.011 REMARK 3 BOND ANGLES (DEGREES) : 1.500 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 22.80 REMARK 3 IMPROPER ANGLES (DEGREES) : 0.950 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : RESTRAINED REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : 1.640 ; 1.500 REMARK 3 MAIN-CHAIN ANGLE (A**2) : 2.610 ; 2.000 REMARK 3 SIDE-CHAIN BOND (A**2) : 2.250 ; 2.000 REMARK 3 SIDE-CHAIN ANGLE (A**2) : 3.300 ; 2.500 REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : FLAT MODEL REMARK 3 KSOL : 0.35 REMARK 3 BSOL : 40.27 REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PROTEIN_REP.PARAM REMARK 3 PARAMETER FILE 2 : WATER_REP.PARAM REMARK 3 PARAMETER FILE 3 : SO4.PAR REMARK 3 PARAMETER FILE 4 : NMN.PAR REMARK 3 PARAMETER FILE 5 : NULL REMARK 3 TOPOLOGY FILE 1 : PROTEIN.TOP REMARK 3 TOPOLOGY FILE 2 : WATER.TOP REMARK 3 TOPOLOGY FILE 3 : SO4.TOP REMARK 3 TOPOLOGY FILE 4 : NMN.TOP REMARK 3 TOPOLOGY FILE 5 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 1NUP COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 05-FEB-03. REMARK 100 THE DEPOSITION ID IS D_1000018221. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 06-NOV-03 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 6.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU RUH3R REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.5418 REMARK 200 MONOCHROMATOR : MIRRORS REMARK 200 OPTICS : OSMIC MIRROR REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : RIGAKU RAXIS IV REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 37359 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.900 REMARK 200 RESOLUTION RANGE LOW (A) : 40.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 98.9 REMARK 200 DATA REDUNDANCY : 6.700 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : 0.03400 REMARK 200 FOR THE DATA SET : 49.0000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.90 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.93 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.9 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : 0.22300 REMARK 200 FOR SHELL : 8.800 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: AMORE REMARK 200 STARTING MODEL: PDB ENTRY 1KQN REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 43.49 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.19 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: NA CADODALYTE, LITHIUM SULPHATE, PEG REMARK 280 400, PH 6.5, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 43 21 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z+1/2 REMARK 290 3555 -Y+1/2,X+1/2,Z+3/4 REMARK 290 4555 Y+1/2,-X+1/2,Z+1/4 REMARK 290 5555 -X+1/2,Y+1/2,-Z+3/4 REMARK 290 6555 X+1/2,-Y+1/2,-Z+1/4 REMARK 290 7555 Y,X,-Z REMARK 290 8555 -Y,-X,-Z+1/2 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 73.14550 REMARK 290 SMTRY1 3 0.000000 -1.000000 0.000000 39.77050 REMARK 290 SMTRY2 3 1.000000 0.000000 0.000000 39.77050 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 109.71825 REMARK 290 SMTRY1 4 0.000000 1.000000 0.000000 39.77050 REMARK 290 SMTRY2 4 -1.000000 0.000000 0.000000 39.77050 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 36.57275 REMARK 290 SMTRY1 5 -1.000000 0.000000 0.000000 39.77050 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 39.77050 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 109.71825 REMARK 290 SMTRY1 6 1.000000 0.000000 0.000000 39.77050 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 39.77050 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 36.57275 REMARK 290 SMTRY1 7 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY2 7 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 8 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY2 8 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 73.14550 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 300 REMARK: BIOLOGICAL ASSEMBLY IS TETRAMER AND REMARK 300 IS GENENRATED BY TWO FOLD AXIS : Y,X,-Z REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TETRAMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TETRAMERIC REMARK 350 SOFTWARE USED: PISA,PQS REMARK 350 TOTAL BURIED SURFACE AREA: 13750 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 34450 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -146.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 2 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT2 2 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 375 REMARK 375 SPECIAL POSITION REMARK 375 THE FOLLOWING ATOMS ARE FOUND TO BE WITHIN 0.15 ANGSTROMS REMARK 375 OF A SYMMETRY RELATED ATOM AND ARE ASSUMED TO BE ON SPECIAL REMARK 375 POSITIONS. REMARK 375 REMARK 375 ATOM RES CSSEQI REMARK 375 HOH B 569 LIES ON A SPECIAL POSITION. REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 1 REMARK 465 LYS A 2 REMARK 465 ARG A 106 REMARK 465 SER A 107 REMARK 465 PRO A 108 REMARK 465 PRO A 109 REMARK 465 GLN A 110 REMARK 465 MET A 111 REMARK 465 GLU A 112 REMARK 465 GLY A 113 REMARK 465 PRO A 114 REMARK 465 ASP A 115 REMARK 465 HIS A 116 REMARK 465 GLY A 117 REMARK 465 LYS A 118 REMARK 465 ALA A 119 REMARK 465 LEU A 120 REMARK 465 PHE A 121 REMARK 465 SER A 122 REMARK 465 THR A 123 REMARK 465 PRO A 124 REMARK 465 ALA A 125 REMARK 465 GLY A 236 REMARK 465 SER A 237 REMARK 465 THR A 238 REMARK 465 TRP A 239 REMARK 465 LYS A 240 REMARK 465 GLY A 241 REMARK 465 LYS A 242 REMARK 465 SER A 243 REMARK 465 THR A 244 REMARK 465 GLN A 245 REMARK 465 SER A 246 REMARK 465 THR A 247 REMARK 465 GLU A 248 REMARK 465 GLY A 249 REMARK 465 LYS A 250 REMARK 465 THR A 251 REMARK 465 SER A 252 REMARK 465 MET B 1 REMARK 465 LYS B 2 REMARK 465 SER B 107 REMARK 465 PRO B 108 REMARK 465 PRO B 109 REMARK 465 GLN B 110 REMARK 465 MET B 111 REMARK 465 GLU B 112 REMARK 465 GLY B 113 REMARK 465 PRO B 114 REMARK 465 ASP B 115 REMARK 465 HIS B 116 REMARK 465 GLY B 117 REMARK 465 LYS B 118 REMARK 465 ALA B 119 REMARK 465 LEU B 120 REMARK 465 PHE B 121 REMARK 465 SER B 122 REMARK 465 THR B 123 REMARK 465 PRO B 124 REMARK 465 ALA B 125 REMARK 465 ALA B 126 REMARK 465 LYS B 235 REMARK 465 GLY B 236 REMARK 465 SER B 237 REMARK 465 THR B 238 REMARK 465 TRP B 239 REMARK 465 LYS B 240 REMARK 465 GLY B 241 REMARK 465 LYS B 242 REMARK 465 SER B 243 REMARK 465 THR B 244 REMARK 465 GLN B 245 REMARK 465 SER B 246 REMARK 465 THR B 247 REMARK 465 GLU B 248 REMARK 465 GLY B 249 REMARK 465 LYS B 250 REMARK 465 THR B 251 REMARK 465 SER B 252 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 SER A 169 CB OG REMARK 470 SER B 169 CB OG REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 NE2 GLN A 211 O HOH A 743 2.12 REMARK 500 OH TYR B 53 O2P NMN B 402 2.18 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 TRP A 77 -8.11 -140.76 REMARK 500 SER A 169 -6.57 89.53 REMARK 500 ASN A 198 -76.67 63.45 REMARK 500 GLU A 199 50.50 27.05 REMARK 500 TRP B 77 -10.98 -140.74 REMARK 500 ASN B 146 -2.33 64.62 REMARK 500 PHE B 160 -133.22 -110.04 REMARK 500 SER B 169 -0.26 84.90 REMARK 500 GLU B 199 76.78 -112.00 REMARK 500 TYR B 217 -2.27 74.74 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 A 301 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 A 302 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 B 303 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 B 304 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE NMN A 401 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE NMN B 402 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1NUQ RELATED DB: PDB REMARK 900 THE SAME PROTEIN COMPLEXED WITH NAAD REMARK 900 RELATED ID: 1NUR RELATED DB: PDB REMARK 900 THE SAME PROTEIN REMARK 900 RELATED ID: 1NUS RELATED DB: PDB REMARK 900 THE SAME PROTEIN COMPLEXED WITH NMN AND ATP ANALOG REMARK 900 RELATED ID: 1NUT RELATED DB: PDB REMARK 900 THE SAME PROTEIN COMPLEXED WITH ATP ANALOG REMARK 900 RELATED ID: 1NUU RELATED DB: PDB REMARK 900 THE SAME PROTEIN COMPLEXED WITH NAD DBREF 1NUP A 1 252 UNP Q96T66 NMNA3_HUMAN 1 252 DBREF 1NUP B 1 252 UNP Q96T66 NMNA3_HUMAN 1 252 SEQRES 1 A 252 MET LYS SER ARG ILE PRO VAL VAL LEU LEU ALA CYS GLY SEQRES 2 A 252 SER PHE ASN PRO ILE THR ASN MET HIS LEU ARG MET PHE SEQRES 3 A 252 GLU VAL ALA ARG ASP HIS LEU HIS GLN THR GLY MET TYR SEQRES 4 A 252 GLN VAL ILE GLN GLY ILE ILE SER PRO VAL ASN ASP THR SEQRES 5 A 252 TYR GLY LYS LYS ASP LEU ALA ALA SER HIS HIS ARG VAL SEQRES 6 A 252 ALA MET ALA ARG LEU ALA LEU GLN THR SER ASP TRP ILE SEQRES 7 A 252 ARG VAL ASP PRO TRP GLU SER GLU GLN ALA GLN TRP MET SEQRES 8 A 252 GLU THR VAL LYS VAL LEU ARG HIS HIS HIS SER LYS LEU SEQRES 9 A 252 LEU ARG SER PRO PRO GLN MET GLU GLY PRO ASP HIS GLY SEQRES 10 A 252 LYS ALA LEU PHE SER THR PRO ALA ALA VAL PRO GLU LEU SEQRES 11 A 252 LYS LEU LEU CYS GLY ALA ASP VAL LEU LYS THR PHE GLN SEQRES 12 A 252 THR PRO ASN LEU TRP LYS ASP ALA HIS ILE GLN GLU ILE SEQRES 13 A 252 VAL GLU LYS PHE GLY LEU VAL CYS VAL GLY ARG VAL SER SEQRES 14 A 252 HIS ASP PRO LYS GLY TYR ILE ALA GLU SER PRO ILE LEU SEQRES 15 A 252 ARG MET HIS GLN HIS ASN ILE HIS LEU ALA LYS GLU PRO SEQRES 16 A 252 VAL GLN ASN GLU ILE SER ALA THR TYR ILE ARG ARG ALA SEQRES 17 A 252 LEU GLY GLN GLY GLN SER VAL LYS TYR LEU ILE PRO ASP SEQRES 18 A 252 ALA VAL ILE THR TYR ILE LYS ASP HIS GLY LEU TYR THR SEQRES 19 A 252 LYS GLY SER THR TRP LYS GLY LYS SER THR GLN SER THR SEQRES 20 A 252 GLU GLY LYS THR SER SEQRES 1 B 252 MET LYS SER ARG ILE PRO VAL VAL LEU LEU ALA CYS GLY SEQRES 2 B 252 SER PHE ASN PRO ILE THR ASN MET HIS LEU ARG MET PHE SEQRES 3 B 252 GLU VAL ALA ARG ASP HIS LEU HIS GLN THR GLY MET TYR SEQRES 4 B 252 GLN VAL ILE GLN GLY ILE ILE SER PRO VAL ASN ASP THR SEQRES 5 B 252 TYR GLY LYS LYS ASP LEU ALA ALA SER HIS HIS ARG VAL SEQRES 6 B 252 ALA MET ALA ARG LEU ALA LEU GLN THR SER ASP TRP ILE SEQRES 7 B 252 ARG VAL ASP PRO TRP GLU SER GLU GLN ALA GLN TRP MET SEQRES 8 B 252 GLU THR VAL LYS VAL LEU ARG HIS HIS HIS SER LYS LEU SEQRES 9 B 252 LEU ARG SER PRO PRO GLN MET GLU GLY PRO ASP HIS GLY SEQRES 10 B 252 LYS ALA LEU PHE SER THR PRO ALA ALA VAL PRO GLU LEU SEQRES 11 B 252 LYS LEU LEU CYS GLY ALA ASP VAL LEU LYS THR PHE GLN SEQRES 12 B 252 THR PRO ASN LEU TRP LYS ASP ALA HIS ILE GLN GLU ILE SEQRES 13 B 252 VAL GLU LYS PHE GLY LEU VAL CYS VAL GLY ARG VAL SER SEQRES 14 B 252 HIS ASP PRO LYS GLY TYR ILE ALA GLU SER PRO ILE LEU SEQRES 15 B 252 ARG MET HIS GLN HIS ASN ILE HIS LEU ALA LYS GLU PRO SEQRES 16 B 252 VAL GLN ASN GLU ILE SER ALA THR TYR ILE ARG ARG ALA SEQRES 17 B 252 LEU GLY GLN GLY GLN SER VAL LYS TYR LEU ILE PRO ASP SEQRES 18 B 252 ALA VAL ILE THR TYR ILE LYS ASP HIS GLY LEU TYR THR SEQRES 19 B 252 LYS GLY SER THR TRP LYS GLY LYS SER THR GLN SER THR SEQRES 20 B 252 GLU GLY LYS THR SER HET SO4 A 301 5 HET SO4 A 302 5 HET NMN A 401 22 HET SO4 B 303 5 HET SO4 B 304 5 HET NMN B 402 44 HETNAM SO4 SULFATE ION HETNAM NMN BETA-NICOTINAMIDE RIBOSE MONOPHOSPHATE HETSYN NMN NICOTINAMIDE MONONUCLEOTIDE FORMUL 3 SO4 4(O4 S 2-) FORMUL 5 NMN 2(C11 H16 N2 O8 P 1+) FORMUL 9 HOH *276(H2 O) HELIX 1 1 THR A 19 THR A 36 1 18 HELIX 2 2 ALA A 60 LEU A 72 1 13 HELIX 3 3 GLN A 73 SER A 75 5 3 HELIX 4 4 PRO A 82 GLN A 87 1 6 HELIX 5 5 GLU A 92 LEU A 105 1 14 HELIX 6 6 ALA A 136 PHE A 142 1 7 HELIX 7 7 LYS A 149 PHE A 160 1 12 HELIX 8 8 ASP A 171 SER A 179 1 9 HELIX 9 9 SER A 179 HIS A 185 1 7 HELIX 10 10 SER A 201 GLN A 211 1 11 HELIX 11 11 PRO A 220 HIS A 230 1 11 HELIX 12 12 THR B 19 GLY B 37 1 19 HELIX 13 13 ALA B 60 GLN B 73 1 14 HELIX 14 14 PRO B 82 GLN B 87 1 6 HELIX 15 15 GLU B 92 ARG B 106 1 15 HELIX 16 16 ALA B 136 PHE B 142 1 7 HELIX 17 17 LYS B 149 LYS B 159 1 11 HELIX 18 18 ASP B 171 SER B 179 1 9 HELIX 19 19 SER B 179 MET B 184 1 6 HELIX 20 20 HIS B 185 HIS B 187 5 3 HELIX 21 21 SER B 201 GLN B 211 1 11 HELIX 22 22 PRO B 220 HIS B 230 1 11 SHEET 1 A 6 ILE A 78 VAL A 80 0 SHEET 2 A 6 TYR A 39 PRO A 48 1 N ILE A 46 O ARG A 79 SHEET 3 A 6 ILE A 5 GLY A 13 1 N ALA A 11 O ILE A 45 SHEET 4 A 6 GLU A 129 GLY A 135 1 O LEU A 133 N LEU A 10 SHEET 5 A 6 LEU A 162 VAL A 165 1 O VAL A 163 N CYS A 134 SHEET 6 A 6 ILE A 189 ALA A 192 1 O HIS A 190 N LEU A 162 SHEET 1 B 6 ILE B 78 VAL B 80 0 SHEET 2 B 6 TYR B 39 PRO B 48 1 N GLY B 44 O ARG B 79 SHEET 3 B 6 ILE B 5 GLY B 13 1 N VAL B 7 O ILE B 42 SHEET 4 B 6 GLU B 129 GLY B 135 1 O LEU B 133 N LEU B 10 SHEET 5 B 6 LEU B 162 VAL B 165 1 O VAL B 163 N LEU B 132 SHEET 6 B 6 ILE B 189 ALA B 192 1 O ALA B 192 N CYS B 164 CISPEP 1 ASN A 16 PRO A 17 0 0.22 CISPEP 2 ASN B 16 PRO B 17 0 0.36 SITE 1 AC1 5 LYS A 95 ARG A 98 HIS A 152 HOH A 663 SITE 2 AC1 5 HOH A 683 SITE 1 AC2 7 LYS A 56 ALA A 202 THR A 203 ARG A 206 SITE 2 AC2 7 HOH A 524 HOH A 584 HOH A 609 SITE 1 AC3 5 LYS B 95 ARG B 98 LYS B 149 HIS B 152 SITE 2 AC3 5 HOH B 691 SITE 1 AC4 9 SER B 14 LYS B 56 ALA B 202 THR B 203 SITE 2 AC4 9 ARG B 206 NMN B 402 HOH B 566 HOH B 611 SITE 3 AC4 9 HOH B 639 SITE 1 AC5 13 CYS A 12 GLY A 13 TYR A 53 TRP A 90 SITE 2 AC5 13 GLU A 92 THR A 93 LEU A 147 TRP A 148 SITE 3 AC5 13 HOH A 512 HOH A 527 HOH A 532 HOH A 561 SITE 4 AC5 13 HOH A 712 SITE 1 AC6 16 CYS B 12 GLY B 13 SER B 14 VAL B 49 SITE 2 AC6 16 TYR B 53 TRP B 90 GLU B 92 THR B 93 SITE 3 AC6 16 LEU B 147 TRP B 148 SO4 B 304 HOH B 503 SITE 4 AC6 16 HOH B 540 HOH B 565 HOH B 568 HOH B 599 CRYST1 79.541 79.541 146.291 90.00 90.00 90.00 P 43 21 2 16 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.012572 0.000000 0.000000 0.00000 SCALE2 0.000000 0.012572 0.000000 0.00000 SCALE3 0.000000 0.000000 0.006836 0.00000